Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$26,559,343
-$7,449,568 QoQ
Shares Held
105,545
-32.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#522
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $264,283,617 across 13 Drug Manufacturers - General names. ABBV ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
88,942 | $106,679,711 | |
| 2 | MRK |
Merck & Co., Inc.
|
248,349 | $31,912,846 | |
| 3 | AZN |
Astrazeneca PLC
|
142,906 | $27,097,835 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
105,545 | $26,559,343 | |
| 5 | JNJ |
Johnson & Johnson
|
95,241 | $24,188,356 | |
| 6 | AMGN |
Amgen Inc
|
56,484 | $20,453,986 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
236,011 | $13,598,953 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
70,944 | $8,963,064 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,559,343 | 105,545 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $34,008,911 | 156,370 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $35,205,510 | 154,079 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $33,340,370 | 143,994 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $26,869,423 | 144,755 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,106,596 | 148,466 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,328,742 | 148,164 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $29,166,216 | 147,692 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $26,916,805 | 156,931 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,788,722 | 125,144 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $19,431,378 | 125,388 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $18,955,811 | 127,169 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $16,766,474 | 124,445 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,084,483 | 88,376 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $14,266,122 | 88,275 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $10,174,996 | 75,814 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $11,071,323 | 72,286 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $8,579,995 | 52,927 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $6,425,136 | 47,453 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,341,443 | 40,247 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,471,695 | 39,699 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,992,885 | 36,896 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,812,718 | 35,583 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $4,858,091 | 55,464 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $6,770,296 | 68,958 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,694,751 | 61,619 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||